Search

Author/Creator Chugh, R

1. 1615PDA phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950). (23rd October 2018)

Authors:
Gounder, M; Schöffski, P; Villalobos, V; Cote, G; Chugh, R; Chen, T W-W; Jahan, T; Loggers, E T; Italiano, A; Gupta, A; Agulnik, M; Attia, S; Jones, R L; van Tine, B A; Demetri, G D D; Roche, M; Sapir, I; Daigle, S; Clawson, A; Stacchiotti, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1892OMolecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950). (23rd October 2018)

Authors:
Daigle, S; Stacchiotti, S; Schöffski, P; Villalobos, V; Cote, G; Chugh, R; Chen, T W-W; Jahan, T; Loggers, E T; Italiano, A; Gupta, A; Agulnik, M; Attia, S; Jones, R L; van Tine, B A; Demetri, G D D; Clawson, A; Roche, M; Blakemore, S; Gounder, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search